Cepheid (NASDAQ: CPHD) reiterated to Buy with price target $60 by Mizuho
Mizuho reiterated Cepheid (NASDAQ: CPHD) to Buy with price target $60. Previously Mizuho rated Buy with price target $65 Cepheid (NASDAQ: CPHD)
on 01/31/2014, when the stock price was $52.86. Since then, Cepheid's stock price has lost 8% as of 08/14/2015's recent price of $48.70. If you would have followed the previous Mizuho's recommendation on CPHD, you would have lost 8% of your investment in 560 days.
, Inc. develops, manufactures and markets microfluidic systems that integrate, automate and accelerate biological testing. Their systems are miniaturized instruments that analyze complex biological samples in a disposable cartridge by combining molecular biology with microfluidic technology that processes small quantities of liquid, typically using components fabricated with computer chip technology. These systems rapidly perform all of the steps required to analyze complex biological samples.